ADIL - CIK 0001513525
ADIAL PHARMACEUTICALS, INC. has filed 533 documents with the SEC between 2011 and 2026. The most frequent type is major company event (143 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Annual report to shareholders | ARS | 2024-09-30 | 2023-12-31 |
| Proxy statement | DEF 14A | 2024-09-27 | 2024-11-12 |
| Quarterly report | 10-Q | 2024-08-13 | 2024-06-30 |
| Quarterly report | 10-Q | 2024-05-14 | 2024-03-31 |
| Major company event | 8-K | 2024-04-26 | 2024-04-24 |
| 424B3 | - | 2024-04-23 | - |
| EFFECT | - | 2024-04-19 | - |
| Prospectus supplement | 424B5 | 2024-04-18 | - |
| Major company event | 8-K | 2024-04-18 | 2024-04-18 |
| Company correspondence | CORRESP | 2024-04-17 | - |
| SEC correspondence | UPLOAD | 2024-04-17 | - |
| Major company event | 8-K | 2024-04-16 | 2024-04-10 |
| Securities registration | S-3 | 2024-04-12 | - |
| Annual report | 10-K | 2024-04-01 | 2023-12-31 |
| Insider trade | 4 | 2024-03-27 | 2024-03-25 |
| Insider trade | 4 | 2024-03-27 | 2024-03-25 |
| Insider trade | 4 | 2024-03-27 | 2024-03-25 |
| Insider trade | 4 | 2024-03-27 | 2024-03-25 |
| Insider trade | 4 | 2024-03-27 | 2024-03-25 |
| Insider trade | 4 | 2024-03-27 | 2024-03-25 |
| Insider trade | 4 | 2024-03-27 | 2024-03-25 |
| D | - | 2024-03-14 | - |
| Major company event | 8-K | 2024-03-06 | 2024-03-01 |
| Passive ownership stake | SC 13G | 2024-02-14 | - |
| Prospectus supplement | 424B5 | 2024-01-25 | - |
| EFFECT | - | 2024-01-24 | - |
| Company correspondence | CORRESP | 2024-01-22 | - |
| SEC correspondence | UPLOAD | 2024-01-19 | - |
| Major company event | 8-K | 2024-01-18 | 2024-01-17 |
| Major company event | 8-K | 2024-01-16 | 2024-01-11 |
| Securities registration | S-3 | 2024-01-12 | - |
| Proxy materials | DEFA14A | 2023-12-15 | - |
| Employee stock plan | S-8 | 2023-12-12 | - |
| Proxy statement | DEF 14A | 2023-12-08 | 2024-01-11 |
| Major company event | 8-K | 2023-11-29 | 2023-11-29 |
| Major company event | 8-K | 2023-11-28 | 2023-11-21 |
| PRE 14A | - | 2023-11-24 | 2023-11-24 |
| 424B3 | - | 2023-11-20 | - |
| EFFECT | - | 2023-11-16 | - |
| Company correspondence | CORRESP | 2023-11-15 | - |
| Major company event | 8-K | 2023-11-14 | 2023-11-14 |
| Quarterly report | 10-Q | 2023-11-14 | 2023-09-30 |
| SEC correspondence | UPLOAD | 2023-11-14 | - |
| IPO registration | S-1 | 2023-11-08 | - |
| Major company event | 8-K | 2023-11-06 | 2023-11-02 |
| Quarterly report (amended) | 10-Q/A | 2023-10-30 | 2023-06-30 |
| Major company event (amended) | 8-K/A | 2023-10-30 | 2023-08-17 |
| NT 10-Q/A | - | 2023-10-30 | 2023-06-30 |
| D | - | 2023-10-26 | - |
| Major company event | 8-K | 2023-10-24 | 2023-10-19 |